A
Anselm K. Gitt
Researcher at Heidelberg University
Publications - 265
Citations - 13930
Anselm K. Gitt is an academic researcher from Heidelberg University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 51, co-authored 261 publications receiving 12897 citations. Previous affiliations of Anselm K. Gitt include European Society of Cardiology & University of Cyprus.
Papers
More filters
Journal ArticleDOI
Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).
TL;DR: The DYSlipidemia International Study found that lipid targets are not met, and two out of three events occurring without any lipid lowering treatment still might happen under statin treatment.
Journal ArticleDOI
Tendencias y contextos en la práctica de la cardiología en los próximos 15 años: La Declaración de Madrid: un documento de la Conferencia Europea sobre el Futuro de la Cardiología, Madrid, 2-3 de junio de 2006
Javier Escaned,Lars Rydén,José Luis Zamorano,Philip A. Poole-Wilson,Valentin Fuster,Anselm K. Gitt,Francisco Fernández-Avilés,Wilma J.M. Scholte op Reimer,Eduardo de Teresa,Luis Alonso-Pulpón,Michal Tendera +10 more
TL;DR: In this article, the authors summarized the conclusions of an expert conference organized by the European Society of Cardiology to discuss the interactions between these phenomena, in an attempt to foresee the potential scenario in which cardiovascular healthcare and research will develop in the near future, and to anticipate solutions to the identified problems.
Journal ArticleDOI
Primary percutaneous coronary intervention and thrombolysis improve survival in patients with ST-elevation myocardial infarction and pre-hospital resuscitation.
TL;DR: Reperfusion therapy improves mortality of patients with ST-elevation myocardial infarction surviving pre-hospital resuscitation, while primary PCI seems to be more effective than thrombolysis.
Journal ArticleDOI
The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
Rupert Bauersachs,Giancarlo Agnelli,Anselm K. Gitt,Manuel Monreal,Patrick Mismetti,Stefan N. Willich,Petra Laeis,Eva-Maria Fronk,Peter Bramlage,Alexander T. Cohen +9 more
TL;DR: In this article, the authors evaluated OAC initiation patterns in clinical practice and found that the most common treatment pattern was heparin-OAC overlap for VKA patents, and OAC only for DOAC patients (49.1%).
Journal ArticleDOI
Effect of an invasive strategy on in-hospital outcome and one-year mortality in women with non-ST-elevation myocardial infarction
Kouraki Kleopatra,Kerstin Muth,Ralf Zahn,Timm Bauer,Oliver Koeth,Claus Jünger,Anselm K. Gitt,Jochen Senges,Uwe Zeymer +8 more
TL;DR: In clinical practice women presenting with NSTEMI have a long-term benefit from an invasive therapeutic strategy with a significant reduction in mortality as well as the composite endpoint of death/MI.